The effect of Nik Ara Company's cleanser in the improvement of patients with acne vulgaris

Phase 2

• Conditions: Acne vulgaris.; Acne vulgaris; L70.0

• Registration Number: IRCT20240207060931N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with mild to moderate acne vulgaris (based on the definition of comedone, papule, and pustule lesions).
Minimum age of 12 people
Willing to participate in the study and complete the consent form.

Exclusion Criteria

People with congenital or acquired immune deficiency
People with atopy and eczema and chronic skin diseases
People with severe acne that is accompanied by nodules and cysts that require systemic treatments
Taking anti-acne treatments in the last 4 weeks such as peeling, laser, and antibiotic drugs
Pregnant women, lactating women and polycystic ovary syndrome patients
People using drugs that cause acne, such as oral and topical steroids and anticonvulsants

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in acne grade. Timepoint: Before the intervention and 56 days after the intervention. Method of measurement: Acne grade will be calculated based on the GAGS system (Global Acne Grading System) on days 0 and 8 weeks after using the drug and placebo.;Changes in skin pH. Timepoint: Before the intervention and 56 days after the intervention. Method of measurement: Skin pH values will be measured by the MST1000 device.;Changes in skin moisture. Timepoint: Before the intervention and 56 days after the intervention. Method of measurement: Skin moisture levels will be measured by the MST1000 device.;Changes in skin fat level. Timepoint: Before the intervention and 56 days after the intervention. Method of measurement: Skin fat level values will be measured by the MST1000 device.;Changes in skin elasticity. Timepoint: Before the intervention and 56 days after the intervention. Method of measurement: Skin elasticity values will be measured by the MST1000 device.